3George ML, Eccles SA, Tutton MG, et al. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging [J]. Clin Cancer Res, 2000,6(8) :3147-3152. 被引量：1
4Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [ J]. Nature, 1996,380(6573 ) :435-439. 被引量：1
6Nguyen JT, Wu P, Clouse ME, et al. Adeno-associated virus-me- diated delivery of anti-angiogenic factous as an antitumor strategy [J]. Cancer Res, 1998,58(24) :5673. 被引量：1
7Noda K, Nishiwaki Y, Kawahara M, et ",tl. Irinotecan plus cispla- tin compared with etoposide plus cisplatin for extensive small-cell lung cancer[J]. N Engl J Med, 2002,346(2) :85-91. 被引量：1
8Hanna N, Bunn PA Jr, Langer C, et al. Randomized phase 1111 tri- al comparing irinotecan/cisplatin in patients with previously un- treated extensive-stage disease small-cell lung cancer[J]. Clin On- col, 2006,24(32) :5175. 被引量：1
9Iizasa T, Chang H, Suzuki M, et al. Overexpression of collagen X V is associated with poor outcome and elevated levels of circulating serum endostatin in non-small cell lung cancer [ J ]. Clin Cancer Res, 2004,10(16) :5361-5366. 被引量：1
